Aigen Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-7,381
Closed -$852K 986
2020
Q4
$852K Sell
7,381
-560
-7% -$62.7K 0.11% 243
2020
Q3
$773K Buy
+7,941
New +$914K 0.1% 314

Other funds holding GWPH

Aigen Investment Management's GWPH Position: Q1 2021 in Review

Aigen Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 7,381 shares — an estimated $852K sold.

Aigen Investment Management first reported a position in GWPH in Q3 2020 and held it in 2 quarters. The position peaked at $852K in Q4 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Aigen Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Aigen Investment Management sold 7,381 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $852K.
  • Aigen Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2020 and held it in 2 quarters.
  • Aigen Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $852K in Q4 2020.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Aigen Investment Management's 13F filing for Q1 2021, filed 11 May 2021.